Endovastec(SH:688016) Sou Hu Cai Jing·2025-11-14 14:52Core Viewpoint - On November 14, 2025, Xinmai Medical (688016) held its first extraordinary general meeting of shareholders, where significant resolutions were passed, including the cancellation of the supervisory board and amendments to the company's articles of association [1]. Group 1: Stock Performance - As of the market close on November 14, 2025, Xinmai Medical's stock price was 102.25 yuan, reflecting a 0.25% increase from the previous trading day [1]. - The stock opened at 101.31 yuan, reached a high of 105.94 yuan, and a low of 101.31 yuan, with a trading volume of 2.12 billion yuan and a turnover rate of 1.65% [1]. Group 2: Shareholder Meeting Resolutions - The extraordinary general meeting approved the proposal to cancel the supervisory board and amend the company's articles of association, which required a special resolution with more than two-thirds of the voting rights held by attending shareholders [1]. - The meeting also included the proposal to purchase liability insurance for directors and senior management, which was voted on separately for minority investors [1].